Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04478279
Title A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sapience Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR


No variant requirements are available.